Bronchogen Peptide: What Survives a Search

The bronchogen peptide is four amino acids, Ala-Asp-Glu-Leu, from the Russian bioregulator family that also produced epithalon. The interesting thing about it is not the compound. It is what happens when you run the two searches anyone would run, in the order they would run them.

Search one: the literature

PubMed returns about twelve records. That number is the first thing most pages repeat, and it is misleading.

Read the titles instead of the count. The majority describe bronchogenic cysts and bronchogenic carcinoma: a neonatal cyst diagnosed by ultrasound, a laparoscopic extirpation of a retroperitoneal cyst, a carcinoma case report. These are unrelated conditions that share a word stem, and the search is matching letters.

What remains after that filter is three papers:

The 2011 paper is also where the sequence is stated.

Search two: the trial registry

ClinicalTrials.gov returns exactly one record, which reads at a glance like a human trial of the compound. It is not.

NCT00746759 is "Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: AEGIS IDE", sponsored by Allegro Diagnostics. Three fields settle it. The study type is observational. The listed intervention is a diagnostic device, and the record itself marks it as not used as an intervention. The purpose is finding gene expression patterns in smokers that flag lung cancer earlier.

Allegro used the name BronchoGen for a diagnostic test. The registry matched the string.

What is left at the end of both

A published sequence, three papers in rats and cells, no human data, no approval in any market, and a research chemical supply chain. That is a thinner base than the search results suggest, and both of the things that inflate it are artefacts of how search works rather than findings about the peptide.

For a fuller reference on the compound, how it is sold and what the bioregulator family shares, there is a dedicated guide to the bronchogen peptide.

The order matters

Run these two searches on any compound in this category and the sequence does the work. Titles before counts, because word stems inflate counts for anything with a common medical root. Study type and lead sponsor before the NCT number, because a registry entry proves a submission was accepted and nothing more.